All In Biotech

Drug Trial Radar · NCT07107672

Mass Balance Study of [14C]X842 in Healthy Adult Male Subjects

Mass Balance and Biotransformation Study of [14C]X842 in Healthy Adult Male Subjects in China

Last checked: Nov 20, 2026Latest source record: Aug 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

6

Actual

Start

Jun 15, 2022

Primary completion

Jul 7, 2022

Study completion Nov 14, 2022

Sponsor

Sponsor type
Industry
First posted
Aug 6, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a single-site, single-dose, non-randomized, open-label study to assess the absorption, metabolism, and excretion profile of \[14C\]X842 in healthy adult male subjects. The study plans to enroll 6 to 8 healthy male subjects in China to ensure at least 4 evaluable subjects.

Conditions

  • Gastroesophageal Reflux Disease

Interventions

  • [14C]X842Drug

    50 mg/100 µCi \[14C\] X842 suspension

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mass balance: the cumulative excretion rateTime frame: 22 days
  2. Tmax (time to maximum observed concentration)Time frame: 22 days
  3. Cmax(maximum concentration)Time frame: 22 days
  4. AUC(area under curve)Time frame: 22 days
  5. t1/2 (terminal elimination half-life)Time frame: 22 days
  6. MRT (mean residence time)Time frame: 22 days
  7. Vd/F(apparent volume of distribution)Time frame: 22 days
  8. whole blood/plasma ratio for the total radioactivity concentration at different time pointsTime frame: 22 days
  9. Percentage of the drug and its metabolites in plasma, urine and feces to the administered doseTime frame: 22 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, Anhui, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.